The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment